2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid

C30H31N5O8 — CID 170012939

IUPAC2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid
SMILESCOc1ccc2nc3c(c(CN4NNC5=C4CCCCCC5OCC(=O)O)c2c1)Cn1c-3cc2c(c1=O)COC(=O)[C@H]2O
InChIInChI=1S/C30H31N5O8/c1-41-15-7-8-21-16(9-15)18(12-35-22-5-3-2-4-6-24(27(22)32-33-35)42-14-25(36)37)19-11-34-23(26(19)31-21)10-17-20(29(34)39)13-43-30(40)28(17)38/h7-10,24,28,32-33,38H,2-6,11-14H2,1H3,(H,36,37)/t24?,28-/m0/s1
InChIKeyVNURUPIBEXPJIX-AZKKKJBWSA-N
MW589.61 g/mol
LogP1.99
Rot. Bonds6

About 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid

2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid (PubChem CID 170012939) has the molecular formula C30H31N5O8 and a molecular weight of 589.61 g/mol. Its IUPAC name is 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid.

Molecular Properties

Compound Name2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid
PubChem CID170012939
Molecular FormulaC30H31N5O8
Molecular Weight589.61 g/mol
Exact Mass589.22
IUPAC Name2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid
SMILESCOc1ccc2nc3c(c(CN4NNC5=C4CCCCCC5OCC(=O)O)c2c1)Cn1c-3cc2c(c1=O)COC(=O)[C@H]2O
InChIInChI=1S/C30H31N5O8/c1-41-15-7-8-21-16(9-15)18(12-35-22-5-3-2-4-6-24(27(22)32-33-35)42-14-25(36)37)19-11-34-23(26(19)31-21)10-17-20(29(34)39)13-43-30(40)28(17)38/h7-10,24,28,32-33,38H,2-6,11-14H2,1H3,(H,36,37)/t24?,28-/m0/s1
InChIKeyVNURUPIBEXPJIX-AZKKKJBWSA-N
XLogP1.99
TPSA164.48 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds6
Heavy Atoms43
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500589.61
LogP ≤ 51.99
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid?
The IUPAC name of 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid (CID 170012939) is 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid.
What is the SMILES notation for 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid?
The canonical SMILES for 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid is COc1ccc2nc3c(c(CN4NNC5=C4CCCCCC5OCC(=O)O)c2c1)Cn1c-3cc2c(c1=O)COC(=O)[C@H]2O.
What is the InChIKey of 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid?
The InChIKey is VNURUPIBEXPJIX-AZKKKJBWSA-N. The full InChI is InChI=1S/C30H31N5O8/c1-41-15-7-8-21-16(9-15)18(12-35-22-5-3-2-4-6-24(27(22)32-33-35)42-14-25(36)37)19-11-34-23(26(19)31-21)10-17-20(29(34)39)13-43-30(40)28(17)38/h7-10,24,28,32-33,38H,2-6,11-14H2,1H3,(H,36,37)/t24?,28-/m0/s1.
What are the key properties of 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid?
2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid has a molecular weight of 589.61 g/mol, XLogP of 1.99, 6 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[1-[[(19S)-19-hydroxy-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-10-yl]methyl]-2,3,4,5,6,7,8,9-octahydrocycloocta[d]triazol-4-yl]oxy]acetic acid is sourced from PubChem (CID 170012939), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).